Showing results (81-90 of 1,602) with videos related to
Sort By:
Pageof 161
JACC. Heart Failure|July 17, 2017
Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate in African-American Patients With Heart FailureBoback Ziaeian, Gregg C Fonarow, Paul A HeidenreichThe American Journal of Cardiology|December 4, 2014
Impact of cardiorespiratory fitness on the obesity paradox in patients with systolic heart failureAdrienne L Clark, Gregg C Fonarow, Tamara B HorwichJournal of the American College of Cardiology|January 3, 2006
B-type natriuretic peptide levels in obese patients with advanced heart failureTamara B Horwich, Michele A Hamilton, Gregg C FonarowJournal of the American College of Cardiology|February 21, 2004
Statin therapy is associated with improved survival in ischemic and non-ischemic heart failureTamara B Horwich, W Robb MacLellan, Gregg C FonarowJournal of Medical Economics|February 19, 2019
Ultrafiltration versus diuretics for the treatment of fluid overload in patients with heart failure: a hospital cost analysisMaria R Costanzo, Gregg C Fonarow, John A RizzoJournal of Cardiac Failure|March 9, 2010
Metformin therapy and outcomes in patients with advanced systolic heart failure and diabetesDigish D Shah, Gregg C Fonarow, Tamara B HorwichThe Canadian Journal of Cardiology|February 10, 2015
Obesity and the obesity paradox in heart failurePritha P Gupta, Gregg C Fonarow, Tamara B HorwichProgress in Cardiovascular Diseases|January 21, 2014
Obesity and the obesity paradox in heart failureAdrienne L Clark, Gregg C Fonarow, Tamara B HorwichCardiovascular Drugs and Therapy|August 19, 2007
Reinforcing a continuum of care: in-hospital initiation of long-term secondary prevention following acute coronary syndromesStanley G Rockson, Emil M deGoma, Gregg C FonarowJournal of Cardiac Failure|May 10, 2011
Waist circumference, body mass index, and survival in systolic heart failure: the obesity paradox revisitedAdrienne L Clark, Gregg C Fonarow, Tamara B HorwichPageof 161